APSR2026-52

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-004
P12
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1200322-46904-APSR26_Poster Template_411644.pptx_433743.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Margarita Isabel Fernandez * Philippines General Hospital Department of Medicine Manila Philippines
Micaella Aliza Empleo - Philippines General Hospital Department of Medicine Manila Philippines
Jonnel Poblete - Philippines General Hospital Department of Medicine Manila Philippines
Ralph Villalobos - Philippines General Hospital Department of Medicine Manila Philippines
Lenora Fernandez - Philippines General Hospital Department of Medicine Manila Philippines
Christian Francisco - Philippines General Hospital Department of Medicine Manila Philippines
 
 
 
 
 
 
 
 
 
Presenting Author Details
Margarita Isabel
Fernandez
mcfernandez7@up.edu.ph
+639985301923
Under 30
Philippines
Original Research
Impact of respiratory multiplex polymerase chain reaction (mpPCR) testing on clinical outcomes of patients with pneumonia in a tertiary government hospital
Maximum 25 words
Abstract Content
Pneumonia remains to be a leading cause of morbidity and mortality globally and in the Philippines. Respiratory cultures are the gold standard for identifying etiologic organisms but delayed and false-negative results lead to prolonged empiric antibiotic use. Respiratory multiplex polymerase chain reaction (mpPCR) testing is validated for rapid detection of respiratory pathogens using nucleic acid amplification assays. This study evaluated the impact of mpPCR testing on antibiotic duration, all-cause mortality, and length of hospital stay among adult patients with pneumonia admitted at the Philippine General Hospital.
A retrospective cohort study was conducted among adults admitted from 2022 to 2025 who underwent mpPCR testing and conventional respiratory cultures. Matched controls with cultures alone were selected based on age, sex, diagnosis, oxygen support, and location. Chi-square, Cox proportional hazards regression, and multivariable models were used in the statistical analysis.
157 patients in the mpPCR group had lower hazards of mortality (HR 0.5 [0.36-0.71, 95% CI], p<0.001) compared to 122 patients in the control group. However, mpPCR testing was associated with longer hospital stay (22 vs 16.5 days,p=0.005), longer empiric antibiotic therapy (6 vs 4 days,p=0.001) and longer total antibiotic duration (12 vs 7.5 days,p=0.011). Admission at the emergency room, non-invasive and invasive pressure ventilation were independently associated with mortality.
mpPCR testing may be associated with decreased mortality risk among hospitalized adults with pneumonia but also longer antibiotic use and hospital stay. Results may have been affected by physician diagnostic practices and confounders such as concurrent infections and advanced directives.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pneumonia, multiplex PCR testing
maximum 3 keywords and no abbreviations, separated by commas
 
263